IONQ

PIPE investors in the transaction received 12.5 million shares at $10.00 per share with additional warrant coverage, providing them better risk-adjusted terms than retail investors who purchased in the open market post-merger.

Underwriter fees totaled $17.25 million, paid primarily to Goldman Sachs and other investment banks involved in the SPAC transaction. Lock-up periods for insiders expired in stages through 2022, with significant insider selling pressure observed during these windows.

Warrant dilution represents a significant overhang: approximately 11.5 million public warrants outstanding with a $11.50 exercise price. If exercised, these warrants would dilute current shareholders by approximately 15-20% depending on timing.

Related party transactions include consulting agreements with board members and advisory fees paid to entities controlled by executives, as disclosed in the company's DEF 14A proxy statements.

GOING CONCERN: IonQ's 2022 10-K contained substantial doubt language from auditors regarding the company's ability to continue operations. This qualification was removed in 2023 following a successful capital raise that extended cash runway.

AUDITOR HISTORY: The company is audited by Ernst & Young LLP, a Big Four accounting firm. No auditor changes or restatements identified in recent filings.

REGULATORY COMPLIANCE: Quantum computing technology faces potential export control restrictions under ITAR and EAR regulations. The company must navigate increasing government oversight of quantum technology transfer, particularly with international partners.

PATENT LANDSCAPE: IonQ holds approximately 450 patents and patent applications, but fundamental quantum computing principles cannot be patented. The company faces patent challenges from established tech companies with larger IP portfolios.

CORPORATE STRUCTURE: Standard Delaware C-Corp structure with single class of common stock. No unusual VIE structures or multi-class voting arrangements identified.